Ticker: STOK

Company: Stoke Therapeutics, Inc.

Person: Jonathan Allan, officer

Transaction date: March 20, 2026

Reporting date: March 24, 2026

Average share price: 33.68535937802647

Sold 9293.0 shares for 313038.04